BRKR Stock Analysis: Buy, Sell, or Hold?
BRKR - Bruker Corporation
$44.29
0.06 (0.14%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
11d
Get Alerted When BRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BRKR is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BRKR is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$73.19
Based on 8.9% avg growth
INTRINSIC VALUE TODAY
$45.44
2.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BRKR is currently trading at $44.29, which is considered oversold relative to its 30-day fair value range of $46.86 to $52.01. The stock's valuation (Forward PE: 20.6) is in line with its historical norms (22.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BRKR is in a strong uptrend. The price is currently testing key support at $43.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.43 (+23.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BRKR is in a strong uptrend. The price is currently testing key support at $43.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.43 (+23.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$46.86 -
$52.01
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding BRKR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.1% below Wall St target ($54.43)
- WARNING: Recommendation downgraded due to -12.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$46.86 -
$52.01
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$43.53
Resistance Level
$53.50
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
20.63
Wall Street Target
$54.43
(+23.1%)
Revenue Growth (YoY)
-0.5%
Profit Margin
-0.6%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
20.6 vs 22.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$42.99
(-3%)
2-Year Target
$41.79
(-6%)
3-Year Target
$40.62
(-8%)
3-Yr Target (if PE normalizes)
(PE: 21→22)
$44.09
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 13.7%)
$70.34
(+59%)
Base:
(SPY PE: 20.6, Growth: 13.7%)
$65.09
(+47%)
Bear:
(PE: 17.5, Growth: 13.7%)
$55.32
(+25%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.6 to 22.4
Stabilization Target:
$48.01
(+8.6%)
PE Expansion Potential:
+8.6%
Last updated: January 30, 2026 10:03 PM ET
Data refreshes hourly during market hours. Next update: 11:03 PM
Data refreshes hourly during market hours. Next update: 11:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Cynthia M Friend
SELL
3535 shares
2025-09-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced BRKR Option Strategies
Professional options setups generated by AI based on today's BRKR price and gamma walls.
